These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9219873)

  • 1. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.
    Xu H; Gutmann DH
    Brain Res; 1997 Jun; 759(1):149-52. PubMed ID: 9219873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of the GAP-related domain from neurofibromin and its implications.
    Scheffzek K; Ahmadian MR; Wiesmüller L; Kabsch W; Stege P; Schmitz F; Wittinghofer A
    EMBO J; 1998 Aug; 17(15):4313-27. PubMed ID: 9687500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.
    Gregory PE; Gutmann DH; Mitchell A; Park S; Boguski M; Jacks T; Wood DL; Jove R; Collins FS
    Somat Cell Mol Genet; 1993 May; 19(3):265-74. PubMed ID: 8332934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
    Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
    Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
    Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
    J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.
    Andersen LB; Ballester R; Marchuk DA; Chang E; Gutmann DH; Saulino AM; Camonis J; Wigler M; Collins FS
    Mol Cell Biol; 1993 Jan; 13(1):487-95. PubMed ID: 8417346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21.
    Martin GA; Viskochil D; Bollag G; McCabe PC; Crosier WJ; Haubruck H; Conroy L; Clark R; O'Connell P; Cawthon RM
    Cell; 1990 Nov; 63(4):843-9. PubMed ID: 2121370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1.
    Klose A; Ahmadian MR; Schuelke M; Scheffzek K; Hoffmeyer S; Gewies A; Schmitz F; Kaufmann D; Peters H; Wittinghofer A; Nürnberg P
    Hum Mol Genet; 1998 Aug; 7(8):1261-8. PubMed ID: 9668168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin.
    Ahmadian MR; Wiesmüller L; Lautwein A; Bischoff FR; Wittinghofer A
    J Biol Chem; 1996 Jul; 271(27):16409-15. PubMed ID: 8663212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody against neurofibromatosis type 1 gene product reacts with a triton-insoluble GTPase activating protein toward ras p21.
    Hattori S; Ohmi N; Maekawa M; Hoshino M; Kawakita M; Nakamura S
    Biochem Biophys Res Commun; 1991 May; 177(1):83-9. PubMed ID: 1904223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids.
    Han JW; McCormick F; Macara IG
    Science; 1991 Apr; 252(5005):576-9. PubMed ID: 1902323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
    Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
    Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conserved region of c-Ha-Ras is required for efficient GTPase stimulation by GTPase activating protein but not neurofibromin.
    Yoder-Hill J; Golubic M; Stacey DW
    J Biol Chem; 1995 Nov; 270(46):27615-21. PubMed ID: 7499225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
    Stone JC; Colleton M; Bottorff D
    Mol Cell Biol; 1993 Dec; 13(12):7311-20. PubMed ID: 8246952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B; Bollag G; Shannon K
    Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
    Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
    J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of cellular activities by GTPase-activating protein and NF1.
    al-Alawi N; Xu G; White R; Clark R; McCormick F; Feramisco JR
    Mol Cell Biol; 1993 Apr; 13(4):2497-503. PubMed ID: 8455625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin.
    Sermon BA; Lowe PN; Strom M; Eccleston JF
    J Biol Chem; 1998 Apr; 273(16):9480-5. PubMed ID: 9545275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.